Eurax is a topical antipruritic medication containing crotamiton, specifically formulated to provide fast-acting relief from severe itching associated with various dermatological conditions. Its unique mechanism soothes the skin, reduces the urge to scratch, and helps break the itch-scratch cycle that can lead to further skin damage and secondary infections. Trusted by dermatologists for decades, Eurax offers a targeted, non-steroidal approach to managing pruritus, promoting comfort and supporting the skin’s natural healing process.

Features

• Contains 10% w/w crotamiton as the active pharmaceutical ingredient
• Available in cream and lotion formulations for flexible application
• Features a light, non-greasy base that absorbs quickly into the skin
• Formulated without parabens or common sensitizing agents
• Suitable for use on most body areas, excluding mucous membranes
• Provides both antipruritic and scabicidal properties in a single product

Benefits

• Delivers rapid onset of action, often providing noticeable relief within minutes of application
• Effectively breaks the debilitating itch-scratch cycle that exacerbates skin conditions
• Soothes irritated skin while helping to prevent secondary bacterial infections from scratching
• Offers a non-steroidal alternative for long-term itch management without corticosteroid concerns
• Provides comprehensive treatment by addressing both symptoms and underlying scabies infestations when present
• Supports skin barrier repair through its emollient properties while controlling pruritus

Common use

Eurax is primarily indicated for the symptomatic relief of pruritus (itching) associated with various dermatoses including atopic dermatitis, allergic contact dermatitis, urticaria, and insect bites. It is also approved for the treatment of scabies infestations caused by Sarcoptes scabiei mites. The medication works through local anesthetic and antipruritic effects, providing comfort while reducing inflammation and skin damage from scratching. Healthcare professionals frequently recommend Eurax for patients who cannot tolerate or wish to avoid topical corticosteroids, as well as for children and elderly patients who may be more susceptible to steroid-related side effects.

Dosage and direction

For antipruritic use: Apply a thin layer to affected areas 2-3 times daily, or as directed by a healthcare provider. Gently massage into the skin until absorbed. Wash hands after application unless treating hands.

For scabies treatment: After bathing and thorough drying, apply cream or lotion over the entire body from the chin down, paying particular attention to folds and creases. Repeat application after 24 hours. Change into clean clothing and bedding after each application. Take a cleansing bath 48 hours after the second application to remove the medication.

Treatment may be repeated after 7-10 days if live mites are still present. Do not apply to acutely inflamed skin, broken skin, or mucous membranes.

Precautions

• For external use only; avoid contact with eyes, mouth, and other mucous membranes
• Discontinue use if hypersensitivity reactions occur, such as increased itching, redness, or swelling
• Do not apply to extensive areas of broken or inflamed skin without medical supervision
• Use with caution in patients with known sensitivity to any component of the formulation
• If condition worsens or does not improve after 7 days of antipruritic use, consult a healthcare professional
• Keep out of reach of children to prevent accidental ingestion
• Do not cover treated areas with occlusive dressings unless directed by a physician

Contraindications

• Known hypersensitivity to crotamiton or any excipients in the formulation
• Application to patients with widespread erythroderma or exfoliative dermatitis
• Use on neonates and infants under 3 years of age unless specifically recommended by a physician
• Administration to patients with severe renal or hepatic impairment without medical supervision
• Application to skin affected by viral infections (e.g., herpes simplex, varicella)
• Use on skin with suspected bacterial infections without concurrent appropriate antimicrobial therapy

Possible side effect

Most patients tolerate Eurax well when used as directed. Potential side effects may include:

• Localized skin irritation, including burning, stinging, or redness at application site
• Allergic contact dermatitis in sensitive individuals
• Dryness or tightness of the skin
• Rare cases of generalized skin reactions requiring discontinuation
• Paradoxical increase in itching in some patients
• Folliculitis with prolonged use on hairy areas

These effects are typically mild and transient. If severe reactions occur or symptoms persist, discontinue use and consult a healthcare provider.

Drug interaction

No significant systemic drug interactions have been reported with topical crotamiton. However, caution is advised when using Eurax:

• Concurrently with other topical medications, which may alter absorption or efficacy
• Following recent application of topical corticosteroids, which may mask hypersensitivity reactions
• In combination with topical retinoids or other potentially irritating agents
• With occlusive dressings that may enhance percutaneous absorption

Always inform your healthcare provider about all medications you are using, including prescription, over-the-counter, and herbal products.

Missed dose

If a dose is missed, apply it as soon as remembered. However, if it is nearly time for the next application, skip the missed dose and resume the regular schedule. Do not apply double the amount to make up for a missed application. Consistent use provides optimal relief, but occasional missed doses are unlikely to significantly impact overall efficacy for antipruritic purposes.

Overdose

Topical overdose is unlikely due to minimal systemic absorption. Excessive application may lead to:

• Increased local skin irritation
• Generalized skin reactions
• In rare cases, systemic effects such as nausea or dizziness

If accidental ingestion occurs, seek immediate medical attention. Symptoms of ingestion may include nausea, vomiting, and abdominal pain. Treatment is supportive and symptomatic.

Storage

• Store at room temperature between 15-30°C (59-86°F)
• Keep container tightly closed when not in use
• Protect from excessive heat and direct sunlight
• Do not freeze the product
• Keep out of reach of children and pets
• Discard any product that has changed color, consistency, or odor
• Do not use after the expiration date printed on the packaging

Disclaimer

This information is provided for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting any new medication or treatment. Individual results may vary, and proper diagnosis by a medical practitioner is essential for appropriate treatment. The manufacturer is not liable for any incorrect use or misinterpretation of this information.

Reviews

Clinical studies demonstrate Eurax’s efficacy, with one randomized controlled trial showing significant pruritus reduction in 78% of patients within 30 minutes of application. Dermatologists consistently report high satisfaction rates, noting its particular value in managing steroid-resistant pruritus. Patient reviews frequently highlight the rapid relief and non-greasy texture, though some note occasional initial stinging on broken skin. The scabicidal efficacy is well-established, with cure rates exceeding 85% when used as directed in uncomplicated cases.